[vc_row][vc_column][vc_column_text]Heart disease and stroke, cancers, diabetes, and chronic respiratory diseases and other noncommunicable diseases (NCDs) cause tens of millions of deaths per year, the majority of which occur during the most productive years of life. NCDs reduce economic output and prevent people around the world of living lives of health and wellbeing.
Creating the conditions that favour sustainable development means taking action to prevent and control NCDs now.
Nine global NCD targets provide a vision for progress by 2025. The WHO Global NCD Action Plan 2013-2020
and other resources provide a roadmap of policies and interventions to realise this vision. When implemented, they will put countries on track to meet the commitments made on NCDs at the United Nations General Assembly in 2011 and 2014, and in the 2030 Agenda for Sustainable Development, including target 3.4 to reduce premature NCD deaths and target 3.5 to strengthen the prevention and treatment of substance abuse, including narcotic drug use and harmful use of alcohol.[/vc_column_text][/vc_column][/vc_row][vc_row][vc_column][vc_btn title=”Download Now” color=”primary” link=”url:https%3A%2F%2Fwww.sancda.org.za%2Fwp-content%2Fuploads%2F2017%2F07%2Fpolicy-brief-reduce-alcohol-1.pdf|||”][/vc_column][/vc_row]
[vc_row][vc_column][vc_column_text]The WHO Framework Convention on Tobacco Control (WHO FCTC)1 and its Parties acknowledge that
the tobacco industry represents a serious threat to the achievement of the Convention’s goals and objectives. In fact, Article 5.3 of the WHO FCTC calls on Parties to protect public health policies from the commercial and other vested interests of the tobacco industry. All governmental sectors – including direct administration, with the executive, legislative and judicial branches, as well as indirect and autonomous administration –are bound to comply with Article 5.3.
In 2009, the Conference of the Parties approved by consensus the guidelines2 to assist Parties in meeting their legal obligations under this article of the WHO FCTC. The Guidelines remind everyone that there is a fundamental and irreconcilable conflict between the tobacco industry’s interests and public health policy interests. On the one hand, the tobacco industry produces and promotes a product that has been proven scientifically to be highly addictive, to harm and kill many and to give rise to a variety of social ills, including increased poverty. On the other hand, many governments and public health workers try to improve the health of their populations by implementing the measures to reduce the use of tobacco contained in the WHO FCTC. The tobacco industry recognizes the impact of these measures on its sales and actively fights against them. Time and time again it has used its resources to kill off these public health policies, water them down when it cannot stop them altogether, and undermine their enforcement when they are passed.
This technical resource presents information to support the implementation of the Article 5.3 Guidelines
by sharing practical action steps and best practices and examples applicable to the implementation of
Article 5.3. It also includes links to supporting materials for easy reference. The technical resource should always be used in association with the text of the WHO FCTC and with its Article 5.3 Guidelines.
The target audience of this publication is government authorities and employees at all levels, since the
Article 5.3 Guidelines are applicable to all branches and levels of government. It is expected that coordinators and managers of tobacco control programmes will take the lead in the dissemination and application of this technical resource, helping countries to comply with Article 5.3. The technical resource may also be useful to people in academia, nongovernmental organizations and the private sector who are involved in implementation of the WHO FCTC.
All the tobacco industry’s tactics and interference with public policy-making are aimed at increasing
tobacco consumption and are detrimental to public health.[/vc_column_text][/vc_column][/vc_row][vc_row][vc_column][vc_btn title=”Download Now” color=”primary” align=”center” link=”url:https%3A%2F%2Fwww.sancda.org.za%2Fwp-content%2Fuploads%2F2017%2F06%2F2012-WHO-Technical-Resource-for-country-implementation-of-FCTC-1.pdf|||”][/vc_column][/vc_row]
[vc_row][vc_column][vc_column_text]Premature death from NCDs continues to be one of the major development challenges in the 21st century. NCDs kill 15 million women and men between the ages of 30 and 70 each year, and leave no country untouched. This burden is rising disproportionately among low-income and lower-middle-income countries, where almost half of premature NCD deaths occur. Within countries, these deaths disproportionally affect the poorest and those furthest behind. The NCD epidemic is driven by poverty, globalization of marketing and trade of health-harming products, rapid urbanization, and population growth. This Progress Monitor is based on the latest data tracked against 10 progress indicators to chart progress in developing national responses. It describes achievements and challenges faced by all countries in fulfilling promises made since the first UN High-level Meeting on NCDs in 2011.[/vc_column_text][/vc_column][/vc_row][vc_row][vc_column][vc_btn title=”Download Now” color=”primary” align=”center” link=”url:https%3A%2F%2Fwww.sancda.org.za%2Fwp-content%2Fuploads%2F2017%2F10%2F9789241513029-eng-1.pdf|||”][/vc_column][/vc_row]
[vc_row][vc_column][vc_column_text]Each year, 16 million people die prematurely before the age of 70 from NCDs. Strikingly, 4 out of 5 of these deaths occur in developing countries, making such diseases one of the major development challenges of the 21st century. If countries don’t change tack on NCDs, an estimated $7 trillion could be lost in developing countries over the next 15 years. This contrasts starkly with the cost of action: $11 billion a year to implement a set of NCD “best buy” interventions in all developing countries.
The 2030 Agenda for Sustainable Development recognizes the huge impact of NCDs worldwide – an issue that the Millennium Development Goals did not address. The aim is to reduce premature deaths from NCDs by one-third by 2030 (SDG target 3.4), strengthen implementation of the World Health Organization Framework Convention on Tobacco Control (3.a), strengthen the prevention and treatment to reduce the harmful use of alcohol (3.5), support the research and development on medicines for NCDs that primarily affect developing countries (3.b), and achieve universal health coverage (3.8). This historic turning point for our world to include NCDs in the scope and character of the Sustainable Development Goals is grounded in the commitments made by world leaders at two high-level meetings of the UN General Assembly in 2011 and 2014 to track the epidemic proportions of NCDs and its impact on development, make prevention the cornerstone of the global response, and strengthen health systems.[/vc_column_text][/vc_column][/vc_row][vc_row][vc_column][vc_btn title=”Download Now” color=”primary” align=”center” link=”url:https%3A%2F%2Fwww.sancda.org.za%2Fwp-content%2Fuploads%2F2017%2F06%2F2015-WHO-NCDs-Progress-Monitor-1.pdf|||”][/vc_column][/vc_row]
[vc_row][vc_column][vc_column_text]Injections are one of the most common health care procedures. Every year at least 16 billion injections are administered worldwide. The vast majority – around 90% – are given in curative care. Immunization injections account for around 5% of all injections, with the remaining covering other indications, including transfusion of blood and blood products, intravenous administration of drugs and fluids and the administration of injectable contraceptives (1, 2).
Injection practices worldwide and especially in low- and middle-income countries (LMICs) include multiple, avoidable unsafe practices that ultimately lead to the large-scale transmission of bloodborne viruses among patients, health care providers and the community at large. While data are not available on the associated burden of all possible diseases, unsafe injection practices would logically impact on other bloodborne diseases transmitted through the re-use of injection equipment e.g. haemorrhagic fevers such as Ebola and Marburg viruses, malaria, and others. Re-use and unsafe practices also increase the risk of bacterial infections and abscesses at the injection site, which can cause long-term damage.[/vc_column_text][/vc_column][/vc_row][vc_row][vc_column width=”1/3″][vc_column_text]
WHO: Injection safety guidelines
[/vc_column_text][vc_btn title=”Download Now” color=”primary” align=”center” link=”url:https%3A%2F%2Fwww.sancda.org.za%2Fwp-content%2Fuploads%2F2017%2F07%2F9789241549820-eng-1.pdf|||”][/vc_column][vc_column width=”1/3″][vc_column_text]
AIDE-MEMOIRE for a national strategy for the safe and appropriate use of injections
[/vc_column_text][vc_btn title=”Download Now” color=”primary” align=”center” link=”url:https%3A%2F%2Fwww.sancda.org.za%2Fwp-content%2Fuploads%2F2017%2F07%2F9789241549820-eng-1.pdf|||”][/vc_column][vc_column width=”1/3″][vc_column_text]
GUIDING PRINCIPLES TO ENSURE INJECTION DEVICE SECURITY
[/vc_column_text][vc_btn title=”Download Now” color=”primary” align=”center” link=”url:https%3A%2F%2Fwww.sancda.org.za%2Fwp-content%2Fuploads%2F2017%2F07%2FGuiding_Principle_Inj-1.pdf|||”][/vc_column][/vc_row]
